Citadel Advisors’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.45M | Sell |
155,768
-27,410
| -15% | -$352K | ﹤0.01% | 6110 |
|
|
2026
Q1 | $1.52M | Sell |
183,178
-49,182
| -21% | -$444K | ﹤0.01% | 6684 |
|
|
2025
Q4 | $2.23M | Sell |
232,360
-156,230
| -40% | -$1.48M | ﹤0.01% | 5704 |
|
|
2025
Q3 | $3.68M | Buy |
388,590
+266,532
| +218% | +$2.24M | ﹤0.01% | 4919 |
|
|
2025
Q2 | $911K | Sell |
122,058
-86,524
| -41% | -$537K | ﹤0.01% | 7317 |
|
|
2025
Q1 | $1.27M | Buy |
208,582
+113,231
| +119% | +$783K | ﹤0.01% | 6424 |
|
|
2024
Q4 | $742K | Buy |
95,351
+30,317
| +47% | +$226K | ﹤0.01% | 7666 |
|
|
2024
Q3 | $527K | Sell |
65,034
-233,503
| -78% | -$1.91M | ﹤0.01% | 8152 |
|
|
2024
Q2 | $2.06M | Buy |
298,537
+142,768
| +92% | +$1.92M | ﹤0.01% | 5238 |
|
|
2024
Q1 | $2.76M | Sell |
155,769
-100,490
| -39% | -$1.59M | ﹤0.01% | 4932 |
|
|
2023
Q4 | $3.97M | Sell |
256,259
-333,249
| -57% | -$4.35M | ﹤0.01% | 4140 |
|
|
2023
Q3 | $8.08M | Buy |
589,508
+79,631
| +16% | +$1.17M | ﹤0.01% | 2952 |
|
|
2023
Q2 | $8.8M | Buy |
509,877
+361,249
| +243% | +$7.39M | ﹤0.01% | 2845 |
|
|
2023
Q1 | $3.57M | Sell |
148,628
-103,008
| -41% | -$2.24M | ﹤0.01% | 4367 |
|
|
2022
Q4 | $4.37M | Buy |
251,636
+32,747
| +15% | +$690K | ﹤0.01% | 4084 |
|
|
2022
Q3 | $5.33M | Buy |
+218,889
| New | +$7.53M | ﹤0.01% | 3757 |
|
|
2022
Q2 | – | Sell |
-46,601
| Closed | -$1.24M | – | 13040 |
|
|
2022
Q1 | $1.63M | Sell |
46,601
-23,049
| -33% | -$871K | ﹤0.01% | 6550 |
|
|
2021
Q4 | $4.12M | Buy |
69,650
+12,429
| +22% | +$860K | ﹤0.01% | 4680 |
|
|
2021
Q3 | $3.81M | Sell |
57,221
-111,964
| -66% | -$6.9M | ﹤0.01% | 4856 |
|
|
2021
Q2 | $10.7M | Sell |
169,185
-74,983
| -31% | -$4.22M | ﹤0.01% | 2973 |
|
|
2021
Q1 | $12.7M | Buy |
244,168
+98,412
| +68% | +$5.98M | ﹤0.01% | 2616 |
|
|
2020
Q4 | $6.4M | Sell |
145,756
-102,839
| -41% | -$4.9M | ﹤0.01% | 3264 |
|
|
2020
Q3 | $11.8M | Buy |
248,595
+149,256
| +150% | +$6.04M | ﹤0.01% | 2095 |
|
|
2020
Q2 | $3M | Sell |
99,339
-127,321
| -56% | -$2.83M | ﹤0.01% | 3867 |
|
|
2020
Q1 | $3.87M | Sell |
226,660
-92,085
| -29% | -$1.61M | ﹤0.01% | 3082 |
|
|
2019
Q4 | $5.25M | Buy |
318,745
+28,316
| +10% | +$421K | ﹤0.01% | 3019 |
|
|
2019
Q3 | $4.75M | Buy |
+290,429
| New | +$5.82M | ﹤0.01% | 3176 |
|
|
2018
Q3 | – | Sell |
-19,445
| Closed | -$307K | – | 9271 |
|
|
2018
Q2 | $307K | Buy |
+19,445
| New | +$207K | ﹤0.01% | 7172 |
|
Other funds holding CYRX
Citadel Advisors's CYRX Position: Q2 2026 in Review
Citadel Advisors reduced its CryoPort (CYRX) stake by 15% in Q2 2026, selling an estimated $352K and leaving 155,768 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #6110.
Citadel Advisors first reported a position in CYRX in Q2 2018 and has held it in 28 quarters since. The position peaked at $12.7M in Q1 2021. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.
- Citadel Advisors held 155,768 shares of CryoPort worth $2.45M as of Q2 2026.
- Citadel Advisors sold 27,410 CryoPort shares in Q2 2026, an estimated $352K.
- CryoPort made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6110 holding.
- Citadel Advisors first reported a position in CryoPort in Q2 2018 and has held it in 28 quarters since.
- Citadel Advisors's CryoPort position peaked at $12.7M in Q1 2021.
- 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.